PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

NCT05390892 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

6000

Enrollment

OTHER

Sponsor class

Conditions

Type2Diabetes
ASCVD

Interventions

DRUG: SGLT2 inhibitor
DRUG: GLP-1 receptor agonist

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]